KR20060120677A - 항고혈압제로서의 카베디롤의 니트로옥시유도체 및 다른베타차단제들 - Google Patents

항고혈압제로서의 카베디롤의 니트로옥시유도체 및 다른베타차단제들 Download PDF

Info

Publication number
KR20060120677A
KR20060120677A KR1020067010491A KR20067010491A KR20060120677A KR 20060120677 A KR20060120677 A KR 20060120677A KR 1020067010491 A KR1020067010491 A KR 1020067010491A KR 20067010491 A KR20067010491 A KR 20067010491A KR 20060120677 A KR20060120677 A KR 20060120677A
Authority
KR
South Korea
Prior art keywords
integer
enantiomers
acceptable salts
diastereomers
pharmacologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020067010491A
Other languages
English (en)
Korean (ko)
Inventor
솔다토 피에로 델
프란체스카 베네디니
엔니오 온기니
Original Assignee
니콕스 에스. 에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니콕스 에스. 에이. filed Critical 니콕스 에스. 에이.
Publication of KR20060120677A publication Critical patent/KR20060120677A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020067010491A 2003-12-02 2004-12-01 항고혈압제로서의 카베디롤의 니트로옥시유도체 및 다른베타차단제들 Withdrawn KR20060120677A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104484 2003-12-02
EP03104484.5 2003-12-02

Publications (1)

Publication Number Publication Date
KR20060120677A true KR20060120677A (ko) 2006-11-27

Family

ID=34639309

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067010491A Withdrawn KR20060120677A (ko) 2003-12-02 2004-12-01 항고혈압제로서의 카베디롤의 니트로옥시유도체 및 다른베타차단제들

Country Status (22)

Country Link
US (1) US7825263B2 (cg-RX-API-DMAC7.html)
EP (1) EP1691804B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007513114A (cg-RX-API-DMAC7.html)
KR (1) KR20060120677A (cg-RX-API-DMAC7.html)
CN (1) CN1886132A (cg-RX-API-DMAC7.html)
AR (1) AR047732A1 (cg-RX-API-DMAC7.html)
AT (1) ATE358478T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004294297A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416584A (cg-RX-API-DMAC7.html)
CA (1) CA2548129A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004005748T2 (cg-RX-API-DMAC7.html)
DK (1) DK1691804T3 (cg-RX-API-DMAC7.html)
ES (1) ES2285549T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20070283T3 (cg-RX-API-DMAC7.html)
IL (1) IL174959A0 (cg-RX-API-DMAC7.html)
NO (1) NO20063057L (cg-RX-API-DMAC7.html)
PL (2) PL380065A1 (cg-RX-API-DMAC7.html)
PT (1) PT1691804E (cg-RX-API-DMAC7.html)
RU (1) RU2006119528A (cg-RX-API-DMAC7.html)
SI (1) SI1691804T1 (cg-RX-API-DMAC7.html)
WO (1) WO2005053685A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200604458B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
WO2007090733A1 (en) * 2006-02-06 2007-08-16 Nicox S.A. Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
CA2641501A1 (en) 2006-02-06 2007-08-16 Nicox S.A. Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
JP2010527401A (ja) 2007-05-14 2010-08-12 タイコ ヘルスケア グループ リミテッド パートナーシップ 抗菌材料および被膜
US8062653B2 (en) * 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US11420995B2 (en) 2017-03-03 2022-08-23 Synovo Gmbh Anti-infective and anti-inflammatory compounds
CN115246774A (zh) * 2021-04-27 2022-10-28 南昌弘益科技有限公司 一类新型双羰基类阿魏酸衍生物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311923B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) * 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
EP1385509A4 (en) * 2001-04-02 2004-06-30 Smithkline Beecham Corp TREATMENT METHOD
DE60222131D1 (de) * 2001-05-28 2007-10-11 Chemtech Res Inc Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi

Also Published As

Publication number Publication date
US20070072854A1 (en) 2007-03-29
ZA200604458B (en) 2007-04-25
DK1691804T3 (da) 2007-07-16
PL380065A1 (pl) 2006-12-11
EP1691804A1 (en) 2006-08-23
HRP20070283T3 (en) 2007-11-30
DE602004005748D1 (de) 2007-05-16
US7825263B2 (en) 2010-11-02
CN1886132A (zh) 2006-12-27
WO2005053685A1 (en) 2005-06-16
ES2285549T3 (es) 2007-11-16
SI1691804T1 (sl) 2007-10-31
JP2007513114A (ja) 2007-05-24
IL174959A0 (en) 2006-08-20
BRPI0416584A (pt) 2007-01-30
PT1691804E (pt) 2007-07-04
AR047732A1 (es) 2006-02-15
ATE358478T1 (de) 2007-04-15
AU2004294297A1 (en) 2005-06-16
PL1691804T3 (pl) 2007-08-31
DE602004005748T2 (de) 2007-12-27
NO20063057L (no) 2006-06-30
RU2006119528A (ru) 2008-01-10
EP1691804B1 (en) 2007-04-04
CA2548129A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
JP4743382B2 (ja) O−置換ヒドロキシアリール誘導体
RU2094430C1 (ru) Акрилоилзамещенные производные пиррола и их фармацевтически приемлемые кислотно-аддитивные соли, фармацевтическая композиция на их основе и способ их получения
FR2530626A1 (fr) Composes de carbostyryle
JP2007500684A (ja) 心臓血管疾患治療用のアンギオテンシン−ii受容体遮断薬としてのロサルタン、バルサルタン、カンデサルタン、テルミサルタン、エプロサルタンおよびオルメサルタンのニトロオキシ誘導体
FR2673427A1 (fr) Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
ZA200501537B (en) Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
JP5247814B2 (ja) 新規ジアゼニウムジオラート誘導体、それを製造する方法、およびそれを含有する薬学的組成物
FR2565587A1 (fr) Derive nouveau de diamide d'amino-acide a caractere acide n-acylique, un sel de celui-ci, un procede de production de celui-ci et un agent anti-ulcereux le contenant
EP1691804B1 (en) Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
WO2007090733A1 (en) Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
EP1753725A1 (fr) Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
HU214827B (hu) 1-(Aril-oxi)-3-(alkil-amino)-2-propanol-nitrát-észterek, és ezeket tartalmazó gyógyászati készítmények
US4948808A (en) Guanidinobenzoic ester derivative
JPH0825997B2 (ja) 3−アミノプロピルオキシフェニル誘導体、その製法およびそれらを含有する医薬組成物
EP1748994B1 (en) Nitrooxyderivatives of antihypertensive drugs
WO2005030706A1 (ja) アミド型カルボキサミド誘導体
CA2231465A1 (en) 2-acylaminobenzamide derivatives and an agent for the prevention and treatment of diseases caused by excessive proliferation of vascular intimal cells
JP2001525398A (ja) 選択的β3アドレナリン作動性アゴニスト
JP3116256B2 (ja) (チオ)ウレア誘導体
BE897208A (fr) Composes de carbostyryle
US5962486A (en) Indole derivatives as prodrugs of 5-HT1 -like receptor agonists
EP0275221B1 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
MXPA06006193A (en) Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
JP2001181279A (ja) ベンゾフラニルピロールカルボキシアミド誘導体
CA2369654A1 (en) N-substituted-n'-substituted urea derivatives and pharmaceutical compositions containing said derivatives

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060529

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid